Chemical analysis and anticancer activity of sesterterpenoid from an endophytic fungus Hypomontagnella monticulosa Zg15SU and its host Zingiber griffithii Baker

Heliyon
2021.0

Abstract

Zingiber griffithii Baker is one of the native Zingiberaceous species in a tropical forest of North Sumatra, Indonesia. Zingiberaceous species have been intensively studied and reported as herbal ingredients in ethnomedicine and currently their endophytic fungal associates were studied for pharmacological importance. Fifteen endophytic fungi were isolated from Zingiber griffithii following morphological and molecular characterization. All isolates exhibited antibacterial properties to at least one of the tested pathogenic bacteria Staphylococcus aureus, Escherichia coli, Methicilin-resistant S. aureus (MRSA), and Enteropathogenic E. coli (EPEC). The isolate, identified as Hypomontagnella monticulosa strain Zg15SU (syn. Hypoxylon monticulosum Mont.) based on its rDNA/ITS sequence, displayed antibacterial activities to all tested pathogens. The EtOAc extract of the H. monticulosum Zg15SU showed the highest activity for gram-negative bacteria, the E. coli and EPEC, while the extract of Z. griffithii rhizome displayed activity only for E. coli. The gas chromatography-mass spectrometry analysis (GC-MS) indicated a major portion of similar compounds found in both the endophytic fungus and plant extract, revealing the compounds of oleic acid, cyclononasiloxane, octadecamethyl, and eicosanoic acid Furthermore, purification and structural elucidation on the EtOAc extract of both Z. griffithii rhizome and H. monticulosa Zg15SU yielded two bioactive compounds: a novel compound, griffithiiene, a terpenoid-alkaloid bearing the skeleton of a scalarane (1) and scalaradial (2) which were confirmed by 1H- (500 MHz) and 13C-NMR (125 MHz) spectroscopy. Importantly, the elucidated compounds showed a cytotoxicity activity against cancer cell lines, the Panc-1, NBT-T2, and HCT116 based on in vitro MTT proliferation assay. This is the first report of Z. griffithii harboring an endophytic fungus, H. monticulosa, which produced potential antibacterial and anticancer metabolites along with its host to be utilized for future prospects. Anticancer, Hypomontagnella monticulosa, North Sumatra, Sesterterpenoid, Zingiber griffithii Baker © 2021

Knowledge Graph

Similar Paper

Chemical analysis and anticancer activity of sesterterpenoid from an endophytic fungus Hypomontagnella monticulosa Zg15SU and its host Zingiber griffithii Baker
Heliyon 2021.0
Chemical profiling of fungal metabolites via the OSMAC approach: Novel identification of Brianthein W from an endophytic fungus, Hypomontagnella monticulosa Zg15SU
Current Research in Microbial Sciences 2024.0
Bioactive Spirobisnaphthalenes from the Endophytic Fungus <i>Berkleasmium</i> sp.
Journal of Natural Products 2014.0
Bioactive metabolites from an endophytic fungus of Aspergillus species isolated from seeds of Gloriosa superba Linn.
Medicinal Chemistry Research 2013.0
Biological activities of extracts from endophytic fungi isolated from<i>Garcinia</i>plants
FEMS Immunology &amp; Medical Microbiology 2007.0
Antibacterial Secondary Metabolites from an Endophytic Fungus, <i>Eupenicillium</i> sp. LG41
Journal of Natural Products 2014.0
Biological activities of endophytic fungi isolated from Annona muricata Linnaeus: a systematic review
Brazilian Journal of Biology 2022.0
Endophytic fungi found in association with <i>Smallanthus sonchifolius</i> (Asteraceae) as resourceful producers of cytotoxic bioactive natural products
Journal of Basic Microbiology 2009.0
Secondary Metabolites of Endophytes Associated with the Zingiberaceae Family and Their Pharmacological Activities
Scientia Pharmaceutica 2022.0
Bioactive extracts and chemical constituents of two endophytic strains of Fusarium oxysporum
Revista Brasileira de Farmacognosia 2012.0